Treatment of egfr mutant-related cancers using a combination of egfr and cdk4/6 inhibitors
WO2020219808A1
Dicarbamate inhibitors of ns5a for treatment of hepatitis c virus infections and related diseases
CN111423515A
CD20/CD47 bispecific antibody and application
TW202102487A
Crystalline and amorphous forms of n-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2h-indazol-5-yl)pyrimidin-2-amine and its salts, and preparation methods and therapeutic uses thereof
WO2020159980A1
2h-indazole derivatives as therapeutic agents for brain cancers and brain metastases
WO2020124060A1
Organophosphorus-substituted compounds as c-met inhibitors and therapeutic uses thereof
CN110898026A
Pharmaceutical composition containing BPI-7711 and preparation method thereof
KR20200115583A
2H-indazole derivatives as CDK4 and CDK6 inhibitors and their therapeutic use
KR20200016969A
N- (2- (2- (dimethylamino) ethoxy) -4-methoxy-5-((4- (1-methyl-1H-indol-3-yl) pyrimidin-2-yl) amino) phenyl Pharmaceutical Formulation of Acrylamide and Its Salts
MX2018015508A
Pharmaceutical salts of n-(2-(2-(dimethylamino)ethoxy)-4-methoxy- 5-((4-(1-methyl-1h-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acryla mide and crystalline forms thereof.
TW201740951A
2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers
SG10201909060SA
Substituted 2-anilinopyrimidine derivatives as egfr modulators
BR112017001058A2
2-h-indazole derived inhibitors as cyclin dependent kinase (cdk) and their therapeutic uses
WO2015164625A1
Aspiration and biopsy needle apparatus and devices and applications thereof
WO2014028914A1
Deuterated icotinib derivatives
EP2694058A2
New indolinone protein kinase inhibitors
WO2004062598A2
Anti-inflammatory and anti-thrombotic compounds and their compositions
US7078409B2
Fused quinazoline derivatives useful as tyrosine kinase inhibitors
